Lab on chip applications: Drug discovery, genomics, diagnostics, proteomics, IVD & POC, high throughput screening, and others.
Protein microarray applications: Expression profiling, proteomics, high throughput screening, diagnostics, drug discovery, and others.
Other array applications: Expression profiling, cancer diagnostics, toxicogenomics, genomics, drug discovery, and others.
On the basis of types:
DNA microarrays, lab on chip, protein microarrays, other arrays (cell arrays and tissue arrays)
On the basis of geography:
North America, Europe, Asia, and Rest of the World.
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. It will also provide market tables for covering the sub-segments. In addition, the report will throw light on more than 20 company profiles covering all the sub-segments.
TABLE OF CONTENTS
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.4 MARKET SHARE
1.5.5 ASSUMPTIONS MADE FOR THE REPORT
2 EXECUTIVE SUMMARY
2.1 OVERVIEW OF THE MARKET
2.2 KEY FINDINGS
2.3.1 APPLICATION OF REVERSE PHASE PROTEIN MICROARRAYS IN CANCER DIAGNOSIS IS A LUCRATIVE INVESTMENT OPTION
3 MARKET OVERVIEW
3.2 BURNING ISSUE
3.2.1 EMERGENCE OF NEW DISEASES & DISEASE COMPLEXITY CATALYZE ADOPTION OF BIOCHIPS IN DIAGNOSTICS
3.3 WINNING IMPERATIVES
3.3.1 STANDARDIZATION IS A NECESSITY
3.3.3 NEED OF CROSS COMPATIBILITY
3.3.4 END-TO-END SOLUTIONS
3.4 MARKET DYNAMICS
Copyright©2010 PR Newswire.
All rights reserved